Moneycontrol PRO
HomeNewsWorldDelayed report on Wuhan wet market reveals crucial details on COVID-19 origin

Delayed report on Wuhan wet market reveals crucial details on COVID-19 origin

The report that was eventually published in June in the journal Scientific Reports, stated that minks, civets, raccoon dogs, and other mammals known to harbour coronaviruses were being sold for years in Wuhan, including in the Huanan wet market – which is linked to several of the earliest known COVID-19 cases.

August 17, 2021 / 19:29 IST
A man wearing face mask stands on a balcony above closed shops blocked by barricades in Wuhan. (Image: Reuters)

The COVID-19 origin story continues to be a mystery mired in contentious geopolitical debate. However, a research paper that could not be published for the past year and a half has been found to contain meticulously collected data and photographic evidence that supported the initial hypothesis — that the COVID-19 pandemic outbreak started from an infected wild animal.

The report that was eventually published in June in the journal Scientific Reports, stated that minks, civets, raccoon dogs, and other mammals known to harbour coronaviruses were being sold for years in Wuhan, including in the Huanan wet market – which is linked to several of the earliest known COVID-19 cases.

Bloomberg reported that the data for the COVID-19 study was collected over 30 months by a virologist named Xiao Xiao, who is associated with the government-funded Key Laboratory of Southwest China Wildlife Resources Conservation and at Hubei University of Traditional Chinese Medicine.

He had started surveying shops selling live wild animals in Wuhan as early as 2017. At the time he was trying to locate the source of a tick-borne, Lyme-like disease that had infected some people years ago. He kept visiting 17 shops in Wuhan until November 2019, when the first few cases of the novel coronavirus disease were detected.

After the pandemic started spreading like wildfire, Xiao had collaborated with another researcher named Zhou Zhaomin along with three seasoned scientists to submit a manuscript to a journal based on his findings from the Wuhan market visits.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

However, to their disappointment, their paper was rejected. Chris Newman, a British ecologist who also co-authored the paper, said: “We had imagined that the journal we sent it to would say, ‘Fantastic! Of course we want these data out as quickly as we can. The World Health Organization would be absolutely thrilled to receive this information…. But it was rejected. They did not think it would have widespread appeal.”

Earlier, Zhang Yongzhen and Edward Holmes -- the scientists who published the first gene sequencing of SARS-CoV-2 – had said: “Unfortunately, the apparent lack of direct animal sampling in the market may mean that it will be difficult, perhaps even impossible, to accurately identify any animal reservoir at this location.”

Notably, Geng Shuang, a spokesman for China’s Foreign Ministry, had denied that “wildlife wet markets” existed in the country. Chinese government researchers are also now dismissing the market hypothesis entirely.

Now, had the study got published in the early half of 2020, the search for the origins of the novel coronavirus could have taken a very different turn since Xiao is believed to have collected blood-sucking ticks from the wild animals that were being sold at the Wuhan market, which could be examined for traces of the coronavirus. Their study would have also helped establish that live animals were sold at the Wuhan market for human consumption. Xiao had collected conclusive evidence to prove the same.

Follow our coverage of the coronavirus crisis here

Moneycontrol News
first published: Aug 17, 2021 07:29 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347